Felix Health
Series B in 2023
Felix Health Inc. is a Canadian company established in 2019 and headquartered in Toronto. It operates an online prescription platform that provides medications for conditions such as erectile dysfunction, hair loss, acne, and birth control. The company aims to modernize healthcare in Canada by offering a seamless and straightforward experience for patients seeking treatment for various health concerns. Through its innovative approach, Felix Health addresses the needs of contemporary consumers in the healthcare sector.
GoBolt, formerly known as Second Closet Incorporated, provides valet self-storage services that enable customers to store their belongings conveniently and securely. Founded in 2017 and based in Toronto, Canada, the company offers a comprehensive solution where customers can schedule pickups and returns of their items. GoBolt delivers boxes for customers to use for storage, then collects these items to be stored in a climate-controlled warehouse. The service is designed to be user-friendly, allowing clients to pay only for the space they utilize, making it an affordable option for those in need of storage solutions.
Ukko Agro
Seed Round in 2021
Ukko Agro is a Toronto-based company that develops a smart agricultural ecosystem designed to optimize pesticide usage and minimize crop losses. Founded in 2017, the company provides technology tools that facilitate efficient on-farm decision-making with minimal time investment from growers. Its ecosystem employs prescriptive models for disease and pest management and integrates seamlessly with external on-farm machinery through the Internet of Things (IoT). By enabling real-time monitoring and predictive analytics, Ukko Agro helps farmers optimize crop inputs, reduce losses, and ultimately achieve higher yields. The company is committed to enhancing sustainability in agriculture by tracking, analyzing, and quantifying the benefits of optimized pesticide use.
Nicoya Lifesciences
Series A in 2021
Nicoya Lifesciences Inc. is a Canadian company based in Kitchener that specializes in developing advanced sensor products for the biotechnology and pharmaceutical industries. Founded in 2012, Nicoya creates instruments designed to analyze biomolecular interactions, including proteins, antibodies, DNA, RNA, and small molecules. Their product lineup includes surface plasmon resonance (SPR) instruments, spectrophotometers, sensor chips, reagents, and accessories, as well as the OpenSPR, a personal label-free biomolecular analysis instrument. In addition to hardware, Nicoya offers software solutions for real-time kinetic analysis, instrument control, and optical peak tracking, enhancing the capabilities of their analytical tools.
GoBolt, formerly known as Second Closet Incorporated, provides valet self-storage services that enable customers to store their belongings conveniently and securely. Founded in 2017 and based in Toronto, Canada, the company offers a comprehensive solution where customers can schedule pickups and returns of their items. GoBolt delivers boxes for customers to use for storage, then collects these items to be stored in a climate-controlled warehouse. The service is designed to be user-friendly, allowing clients to pay only for the space they utilize, making it an affordable option for those in need of storage solutions.
Qvella
Venture Round in 2021
Qvella Corporation is a Toronto-based molecular diagnostics company founded in 2009 by a group of scientists and engineers. The company focuses on transforming clinical microbiology by significantly reducing the time required to obtain results for bloodstream infections. Qvella's innovative Field Activated Sample Treatment (FAST™) technology employs a novel electrical lysing technique, known as e-lysis™, which facilitates the rapid and fully automated detection of infectious agents directly from unenriched biological samples. This capability allows clinicians to identify microorganisms in infected whole blood samples without the lengthy sample processing typically required, ultimately enhancing patient outcomes and saving lives.
GoBolt
Venture Round in 2021
GoBolt, formerly known as Second Closet Incorporated, provides valet self-storage services that enable customers to store their belongings conveniently and securely. Founded in 2017 and based in Toronto, Canada, the company offers a comprehensive solution where customers can schedule pickups and returns of their items. GoBolt delivers boxes for customers to use for storage, then collects these items to be stored in a climate-controlled warehouse. The service is designed to be user-friendly, allowing clients to pay only for the space they utilize, making it an affordable option for those in need of storage solutions.
Felix Health
Series A in 2021
Felix Health Inc. is a Canadian company established in 2019 and headquartered in Toronto. It operates an online prescription platform that provides medications for conditions such as erectile dysfunction, hair loss, acne, and birth control. The company aims to modernize healthcare in Canada by offering a seamless and straightforward experience for patients seeking treatment for various health concerns. Through its innovative approach, Felix Health addresses the needs of contemporary consumers in the healthcare sector.
Qvella
Venture Round in 2020
Qvella Corporation is a Toronto-based molecular diagnostics company founded in 2009 by a group of scientists and engineers. The company focuses on transforming clinical microbiology by significantly reducing the time required to obtain results for bloodstream infections. Qvella's innovative Field Activated Sample Treatment (FAST™) technology employs a novel electrical lysing technique, known as e-lysis™, which facilitates the rapid and fully automated detection of infectious agents directly from unenriched biological samples. This capability allows clinicians to identify microorganisms in infected whole blood samples without the lengthy sample processing typically required, ultimately enhancing patient outcomes and saving lives.
Nicoya Lifesciences
Series A in 2020
Nicoya Lifesciences Inc. is a Canadian company based in Kitchener that specializes in developing advanced sensor products for the biotechnology and pharmaceutical industries. Founded in 2012, Nicoya creates instruments designed to analyze biomolecular interactions, including proteins, antibodies, DNA, RNA, and small molecules. Their product lineup includes surface plasmon resonance (SPR) instruments, spectrophotometers, sensor chips, reagents, and accessories, as well as the OpenSPR, a personal label-free biomolecular analysis instrument. In addition to hardware, Nicoya offers software solutions for real-time kinetic analysis, instrument control, and optical peak tracking, enhancing the capabilities of their analytical tools.
GoBolt, formerly known as Second Closet Incorporated, provides valet self-storage services that enable customers to store their belongings conveniently and securely. Founded in 2017 and based in Toronto, Canada, the company offers a comprehensive solution where customers can schedule pickups and returns of their items. GoBolt delivers boxes for customers to use for storage, then collects these items to be stored in a climate-controlled warehouse. The service is designed to be user-friendly, allowing clients to pay only for the space they utilize, making it an affordable option for those in need of storage solutions.
Qvella
Venture Round in 2019
Qvella Corporation is a Toronto-based molecular diagnostics company founded in 2009 by a group of scientists and engineers. The company focuses on transforming clinical microbiology by significantly reducing the time required to obtain results for bloodstream infections. Qvella's innovative Field Activated Sample Treatment (FAST™) technology employs a novel electrical lysing technique, known as e-lysis™, which facilitates the rapid and fully automated detection of infectious agents directly from unenriched biological samples. This capability allows clinicians to identify microorganisms in infected whole blood samples without the lengthy sample processing typically required, ultimately enhancing patient outcomes and saving lives.
Qvella Corporation is a Toronto-based molecular diagnostics company founded in 2009 by a group of scientists and engineers. The company focuses on transforming clinical microbiology by significantly reducing the time required to obtain results for bloodstream infections. Qvella's innovative Field Activated Sample Treatment (FAST™) technology employs a novel electrical lysing technique, known as e-lysis™, which facilitates the rapid and fully automated detection of infectious agents directly from unenriched biological samples. This capability allows clinicians to identify microorganisms in infected whole blood samples without the lengthy sample processing typically required, ultimately enhancing patient outcomes and saving lives.
Clearwater Clinical Limited, founded in 2004 and based in Ottawa, Canada, specializes in the design and manufacture of mobile medical-grade devices aimed at enhancing clinical practices in the endoscopy and audiology markets. The company offers innovative products such as ClearSCOPE, a mobile endoscope adaptor that supports various medical applications, including ENT and urology exams, as well as veterinary and industrial uses. Additionally, Clearwater Clinical produces ShoeBOX, an iPad-based audiometer designed for screening and diagnostic testing in diverse settings such as clinics, schools, and telemedicine applications. Another key product is DizzyFIX, which facilitates the Epley Maneuver, a common treatment for vertigo caused by benign paroxysmal positional vertigo. The company, led by Dr. Matthew Bromwich and his team, is committed to providing affordable solutions that leverage mobile technology to improve patient care.
Qvella Corporation is a Toronto-based molecular diagnostics company founded in 2009 by a group of scientists and engineers. The company focuses on transforming clinical microbiology by significantly reducing the time required to obtain results for bloodstream infections. Qvella's innovative Field Activated Sample Treatment (FAST™) technology employs a novel electrical lysing technique, known as e-lysis™, which facilitates the rapid and fully automated detection of infectious agents directly from unenriched biological samples. This capability allows clinicians to identify microorganisms in infected whole blood samples without the lengthy sample processing typically required, ultimately enhancing patient outcomes and saving lives.
Qvella Corporation is a Toronto-based molecular diagnostics company founded in 2009 by a group of scientists and engineers. The company focuses on transforming clinical microbiology by significantly reducing the time required to obtain results for bloodstream infections. Qvella's innovative Field Activated Sample Treatment (FAST™) technology employs a novel electrical lysing technique, known as e-lysis™, which facilitates the rapid and fully automated detection of infectious agents directly from unenriched biological samples. This capability allows clinicians to identify microorganisms in infected whole blood samples without the lengthy sample processing typically required, ultimately enhancing patient outcomes and saving lives.